Latest Insider Transactions at United Health Products, Inc. (UEEC)
This section provides a real-time view of insider transactions for United Health Products, Inc. (UEEC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of United Health Products, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of United Health Products, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2023
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
300,000
-22.15%
|
$0
$0.19 P/Share
|
|
Apr 17
2023
|
Brian David Thom Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
309,375
+18.59%
|
$0
$0.22 P/Share
|
|
Jan 13
2023
|
Brian David Thom Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+19.65%
|
$0
$0.27 P/Share
|
|
Sep 16
2022
|
Brian David Thom Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+11.88%
|
$0
$0.3 P/Share
|
|
Jun 06
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
43,945
-4.57%
|
$0
$0.47 P/Share
|
|
Jun 03
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,055
-5.51%
|
$0
$0.49 P/Share
|
|
Jun 02
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
127,100
-11.1%
|
$0
$0.51 P/Share
|
|
May 04
2022
|
Brian David Thom Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
300,000
+20.76%
|
$0
$0.42 P/Share
|
|
Jan 03
2022
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
220,000
-16.07%
|
$0
$0.54 P/Share
|
|
Nov 22
2021
|
Brian David Thom Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
134,000
-8.49%
|
$0
$0.76 P/Share
|
|
Nov 22
2021
|
Brian David Thom Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300,000
+15.97%
|
$0
$0.5 P/Share
|
|
Oct 14
2021
|
Brian David Thom Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,102
+2.08%
|
$0
$0.95 P/Share
|
|
Mar 31
2021
|
Kristofer Heaton Principal Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,666
+10.32%
|
$0
$0.5 P/Share
|
|
Mar 31
2021
|
Brian David Thom Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,220,272
+32.61%
|
$0
$0.5 P/Share
|
|
Mar 31
2021
|
Louis Schiliro COO |
BUY
Exercise of conversion of derivative security
|
Direct |
80,173
+2.08%
|
$0
$0.5 P/Share
|
|
Jan 06
2021
|
Douglas K Beplate CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,730,000
+46.19%
|
$0
$0.56 P/Share
|
|
Jan 06
2021
|
Louis Schiliro COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,000,000
+35.09%
|
$2,000,000
$1.04 P/Share
|
|
Jan 06
2021
|
Kristofer Heaton Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+19.8%
|
$100,000
$1.04 P/Share
|
|
Nov 05
2019
|
Douglas K Beplate CEO |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+35.97%
|
$0
$0.97 P/Share
|